News
Cresset Announces New CEO
May 31 2010
Cresset has appointed Dr Rob Scoffin as Chief Executive Officer of Cresset Group. Rob joins Cresset from CambridgeSoft where, as Vice President of European Operations, he was responsible for significant growth in CambridgeSoft’s European business. Rob replaces Beatrice Leigh, who will now become non-executive Chairman of the Board.
“The appointment of Rob marks an exciting new chapter for Cresset,” said Andy Vinter, Founder and Chief Scientific Officer of Cresset. “Rob has a long track record of close collaboration with customers and successful commercial growth in the computational chemistry market place.” Outgoing CEO and Chairman of the Board, Bea Leigh commented, “We are excited to be working with Rob to further accelerate the company’s development and to achieve our aggressive corporate objectives”.
“This is a fantastic opportunity to join an established company with an excellent scientific reputation, and to help drive growth and enhanced commercial success in the future,” said Rob. “The Cresset team has worked
hard to create a world-leading portfolio of products, and I am looking forward to helping bring those to new markets.
” Rob has a D.Phil. in chemistry from Oxford and has recently been instrumental in the development of Electronic Lab Notebook systems which he has deployed at several major pharmaceutical companies. Prior to CambridgeSoft, Rob was CEO (Software) for Amedis and Senior Product Manager at Oxford Molecular.
Digital Edition
Lab Asia Dec 2025
December 2025
Chromatography Articles- Cutting-edge sample preparation tools help laboratories to stay ahead of the curveMass Spectrometry & Spectroscopy Articles- Unlocking the complexity of metabolomics: Pushi...
View all digital editions
Events
Jan 21 2026 Tokyo, Japan
Jan 28 2026 Tokyo, Japan
Jan 29 2026 New Delhi, India
Feb 07 2026 Boston, MA, USA
Asia Pharma Expo/Asia Lab Expo
Feb 12 2026 Dhaka, Bangladesh



